Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Dentsply Sirona, Inc. (NASDAQ: XRAY) and Encourages Dentsply Investors to Contact the Firm
NEW YORK, May 24, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Dentsply Sirona, Inc. (NASDAQ: XRAY).
Click here to participate in the action.
On December 19, 2018 a complaint was filed alleging that between February 20, 2014 and August 7, 2018, defendants falsely represented the drivers of the company’s financial performance. Specifically, the complaint alleges that defendants attributed the company’s financial performance to the company’s “innovation,” “operational improvement efforts,” “new products,” and “continued investments in sales and marketing” and told investors that these factors helped the company succeed despite the “highly competitive” market for its products.
If you are a long term stockholder of Dentsply, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at firstname.lastname@example.org, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation into Dentsply please go to https://bespc.com/dentsply/. For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.